Glucose 6 Phosphate Deficiency

  • Jerri Chen
  • Suzanne K. W. MankowitzEmail author


Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an enzyme defect with an X-linked recessive inheritance pattern that predisposes to hemolysis in response to certain triggers such as medications, infections, or diet (fava beans). The most important aspect in management of G6PD deficiency in both pregnant and nonpregnant patients is avoidance of triggers. Medications to avoid include antimalarials (dapsone, primaquine), antimycobacterials, antineoplastic agents, methylene blue, and antibiotics such as nitrofurantoin. Common anesthetic agents such as sevoflurane, ketamine, fentanyl, and benzodiazepines have not been reported to cause a hemolytic crisis in G6PD-deficient patients. Most pregnant women with G6PD deficiency can have neuraxial analgesia, and opioids and bupivacaine are safe to use.


Glucose-6-phosphate dehydrogenase G6PD Hemolysis Hemolytic anemia Jaundice Pregnancy Anesthesia 


  1. 1.
    Cappellini M, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371(9606):64–74.CrossRefGoogle Scholar
  2. 2.
    Manganelli G, Masullo U, Passarelli S, Filosa S. Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Cardiovasc Hematol Disord Targets. 2013;13(1):73–82.CrossRefGoogle Scholar
  3. 3.
    Luzzatto L, Nannelli C, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin North Am. 2016;30(2):373–93.CrossRefGoogle Scholar
  4. 4.
    Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol. 2014;164(4):469–80.CrossRefGoogle Scholar
  5. 5.
    Monteiro WM, Franca GP, Melo GC, Queiroz AL, Brito M, Peixoto HM, et al. Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes. Malar J. 2014;13(1):70.CrossRefGoogle Scholar
  6. 6.
    Hecker PA, Leopold JA, Gupte SA, Recchia FA, Stanley WC. Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. Am J Physiol Heart Circ Physiol. 2013;304(4):H491–500.CrossRefGoogle Scholar
  7. 7.
    Ho H-Y, Cheng M-L, Chiu DT-Y. Glucose-6-phosphate dehydrogenase—beyond the realm of red cell biology. Free Radic Res. 2014;48(9):1028–48.CrossRefGoogle Scholar
  8. 8.
    Francis RO, Jhang JS, Pham HP, Hod EA, Zimring JC, Spitalnik SL. Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks. Vox Sang. 2013;105(4):271–82.CrossRefGoogle Scholar
  9. 9.
    Spencer NY, Stanton RC. Glucose 6-phosphate dehydrogenase and the kidney. Curr Opin Nephrol Hypertens. 2017;26(1):43–9.CrossRefGoogle Scholar
  10. 10.
    Yoshida A, Beutler E, Motulsky AG. Human glucose-6-phosphate dehydrogenase variants. Bull World Health Organ. 1971;45(2):243–53.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Mockenhaupt FP, Mandelkow J, Till H, Ehrhardt S, Eggelte TA, Bienzle U. Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency. Trop Med Int Health. 2003;8(2):118–24.CrossRefGoogle Scholar
  12. 12.
    van de Mheen L, Smits SM, Terpstra WE, Leyte A, Bekedam DJ, van den Akker ESA. Haemolytic anaemia after nitrofurantoin treatment in a pregnant woman with G6PD deficiency. BMJ Case Rep. 2014;2014:pii: bcr2013010087.CrossRefGoogle Scholar
  13. 13.
    Abdulhadi NH. Glucose 6 phosphate dehydrogenase (G6PD) deficiency is a possible risk factor for the development of preeclampsia. Med Hypotheses. 2004;62(5):780–2.CrossRefGoogle Scholar
  14. 14.
    Afzal-Ahmed I, Mann GE, Shennan AH, Poston L, Naftalin RJ. Preeclampsia inactivates glucose-6-phosphate dehydrogenase and impairs the redox status of erythrocytes and fetal endothelial cells. Free Radic Biol Med. 2007;42(12):1781–90.CrossRefGoogle Scholar
  15. 15.
    Perkins RP. The significance of glucose-6-phosphate dehydrogenase deficiency in pregnancy. Am J Obstet Gynecol. 1976;125(2):215–23.CrossRefGoogle Scholar
  16. 16.
    Sirugo G, Schaefer EA, Mendy A, Sabeti P, West B, Bailey R, et al. Is G6PD A- deficiency associated with recurrent stillbirths in The Gambia? Am J Med Genet. 2004;128A(1):104–5.CrossRefGoogle Scholar
  17. 17.
    Cramer DW, Wise LA. The epidemiology of recurrent pregnancy loss. Semin Reprod Med. 2000;18(4):331–40.CrossRefGoogle Scholar
  18. 18.
    Keller CC, Joosten M, Middeldorp AM, Knapen MFCM. Fetal anemia caused by the Guadalajara variant of G6PD deficiency. Prenat Diagn. 2015;35(12):1255–7.CrossRefGoogle Scholar
  19. 19.
    Bubp J, Jen M, Matuszewski K. Caring for glucose-6-phosphate dehydrogenase (G6PD)-deficient patients: implications for pharmacy. P T. 2015;40(9):572–4.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Altikat S, Ciftçi M, Büyükokuroğlu ME. In vitro effects of some anesthetic drugs on enzymatic activity of human red blood cell glucose 6-phosphate dehydrogenase. Pol J Pharmacol. 2002;54(1):67–71.PubMedGoogle Scholar
  21. 21.
    Cho YS, Chung BY, Park CW, Kim HO. Seizures and methemoglobinemia after topical application of eutectic mixture of lidocaine and prilocaine on a 3.5-year-old child with molluscum contagiosum and atopic dermatitis. Pediatr Dermatol. 2016;33(5):e284–5.CrossRefGoogle Scholar
  22. 22.
    Guay J. Methemoglobinemia related to local anesthetics: a summary of 242 episodes. Anesth Analg. 2009;108(3):837–45.CrossRefGoogle Scholar
  23. 23.
    Barash M, Reich K, Rademaker D. Lidocaine-induced methemoglobinemia: a clinical reminder. J Am Osteopath Assoc. 2015;115(2):1146–98.Google Scholar
  24. 24.
    Elyassi AR, Rowshan HH. Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature. Anesth Prog. 2009;56(3):86–91.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyColumbia University Medical CenterNew YorkUSA

Personalised recommendations